Francois Martelet, chief executive of NetScientific PLC (LON:NSCI), spoke to Proactive London's Andrew Scott as their portfolio company Glycotest Inc agreed on terms of a funding round.
The US$10mln Series A financing round is with Shanghai Fosun Pharmaceutical, a leading healthcare group based in China.
Price: 4.75 GBX
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Netscientific PLC named herein, including the promotion by the Company of Netscientific PLC in any Content on the Site, the Company receives...
FOR OUR FULL DISCLAIMER CLICK HERE
Top stories from the Proactive Investors UK newsroom: ANGLE PLC (LON:AGL) has received positive results from its Parsortix FDA clinical study for metastatic breast cancer. The 400-subject clinical study will support an application for Class II regulatory clearance for Parsortix in the...
Mining
Retail & consumer
